Serum Institute of India, the manufacturer of vaccines, said its doses expired due to falling demand.
Serum Institute of India Limited (SIIL) a manufacturing company, said the doses had expired due to falling demand,resulting in an abrupt drop in the patentee's revenue. There are high chances that the country will import GlaxoSmithKline's vaccine as there is a severe shortage of its vaccine supply in this facility."
Serum Institute of India (India) is a pharmaceutical company that produces vaccines. The firm distributes human vaccines, veterinary vaccines and animal based vaccines across North America and Europe. Its subsidiaries include Serum-1 Limited, which manufactures different types of pharmaceuticals, and Serum-2 Pvt. Ltd., which engages in import-export activities.